Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas

被引:24
|
作者
Kim, H [1 ]
Ham, EK [1 ]
Kim, YI [1 ]
Chi, JG [1 ]
Lee, HS [1 ]
Park, SH [1 ]
Jung, YM [1 ]
Myung, NK [1 ]
Lee, MJ [1 ]
Jang, JJ [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea
关键词
hepatoblastoma; cyclin D1; cdk4; recurrence;
D O I
10.1016/S0304-3835(98)00151-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Abnormality of the cyclin Dl/cdk4/p16INK4a/pRb pathway during tumorigenesis has recently been reported. Hepatoblastoma is a rare malignant liver tumor of childhood, but underlying abnormalities of cell-cycle regulating protein remain to be elucidated. The expression of cyclin D1, cdk4, p16 and retinoblastoma gene product (pRb) was studied by immunohistochemistry in 17 paraffin-embedded tissues consisting of both tumor and corresponding non-neoplastic tissues. Tumor tissues showed overexpression of cyclin D1 (13/17, 76%) and cdk4 (15/17, 88%). Eleven cases showed co-overexpression of both cyclin D1 and cdk4. No abnormal p16 or pRb expression was noted. In the group with a high score (+4) for cyclin D1 expression, a positive correlation with tumor recurrence was noted (P = 0.043). These data suggest that overexpressed cyclin D1 and cdk4 protein might play an important role in the tumorigenesis of hepatoblastoma and that in the group with high cyclin D1 expression, tumor recurrence may be more frequent. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 50 条
  • [31] Identification of CDK4 sequences involved in cyclin D1 and p16 binding
    Coleman, KG
    Wautlet, BS
    Morrissey, D
    Mulheron, J
    Sedman, SA
    Brinkley, P
    Price, S
    Webster, KR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) : 18869 - 18874
  • [32] Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression
    Yoonjin Lee
    John E. Dominy
    Yoon Jong Choi
    Michael Jurczak
    Nicola Tolliday
    Joao Paulo Camporez
    Helen Chim
    Ji-Hong Lim
    Hai-Bin Ruan
    Xiaoyong Yang
    Francisca Vazquez
    Piotr Sicinski
    Gerald I. Shulman
    Pere Puigserver
    Nature, 2014, 510 : 547 - 551
  • [33] Frequent overexpression of cyclin D1 in sporadic pancreatic endocrine tumours
    Guo, SS
    Wu, X
    Shimoide, AT
    Wong, J
    Moatamed, F
    Sawicki, MP
    JOURNAL OF ENDOCRINOLOGY, 2003, 179 (01) : 73 - 79
  • [34] Cyclin D1, CDK4 expression and cyclin D-1 upregulation by endothelin-1 in rat mesangial cells.
    Huang, HC
    Wang, HY
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2052 - A2052
  • [35] Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
    Matsumoto, M
    Furihata, M
    Ishikawa, T
    Ohtsuki, Y
    Ogoshi, S
    BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 256 - 261
  • [36] CDK4和cyclin D1蛋白在胃癌组织中的表达
    李娟
    吴平平
    姜叙诚
    颜召文
    唐剑敏
    上海交通大学学报(医学版), 2007, (04) : 401 - 404
  • [37] Structural analysis of the CDK4/cyclin D1 substrate recognition site and basis for inhibitor selectivity
    Liu, Shu
    Kirkland, Lindsay
    McInnes, Campbell
    CANCER RESEARCH, 2009, 69
  • [38] Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma
    Jeng-Wei Lu
    Yueh-Min Lin
    Jan-Gowth Chang
    Kun-Tu Yeh
    Rong-Ming Chen
    Jeffrey J. P. Tsai
    Wei-Wen Su
    Rouh-Mei Hu
    Medical Oncology, 2013, 30
  • [39] Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide
    Park, YG
    Park, S
    Lim, SO
    Lee, MS
    Ryu, CK
    Kim, I
    Cho-Chung, YS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (05) : 1213 - 1219
  • [40] Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma
    Lu, Jeng-Wei
    Lin, Yueh-Min
    Chang, Jan-Gowth
    Yeh, Kun-Tu
    Chen, Rong-Ming
    Tsai, Jeffrey J. P.
    Su, Wei-Wen
    Hu, Rouh-Mei
    MEDICAL ONCOLOGY, 2013, 30 (01)